IPP Bureau
Aizon partners with TetraScience to help pharma companies speed up drug manufacturing efficiently
By IPP Bureau - April 06, 2022
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain
By IPP Bureau - April 06, 2022
The new facility is scheduled to start operation in the first half of 2024
Agilent joins AMBIC to advance biomanufacturing
By IPP Bureau - April 05, 2022
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Feedback Medical brings Bleepa to India
By IPP Bureau - April 05, 2022
Announces pilot project for rapid, remote diagnosis of tuberculosis
Enteris BioPharma gets featured on its oral drug delivery technology
By IPP Bureau - April 05, 2022
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Vipergen’s DNA based drug discovery partnership with Theseus Pharma
By IPP Bureau - April 05, 2022
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Abott gets USFDA approval for leadless pacemaker
By IPP Bureau - April 05, 2022
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Trescal launches its single source calibration solution across Australia and New Zealand
By IPP Bureau - April 05, 2022
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
PerkinElmer HTRF and AlphaLISA assay kits for CHO HCP impurities detection and quantification
By IPP Bureau - April 05, 2022
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
Alzamend Neuro appoints Dr. Terri Hunter to its Scientific Advisory Board
By IPP Bureau - April 05, 2022
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
Dr Lal PathLabs to use drones for sample collection and diagnostic access
By IPP Bureau - April 05, 2022
Pilots to be launched across multiple locations in India.
Lupin signs deal with Alvion for cardiometabolic drugs in Southeast Asia
By IPP Bureau - April 05, 2022
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
SRL Diagnostics and Skye Air Mobility join hands to use drones for collection
By IPP Bureau - April 05, 2022
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
By IPP Bureau - April 05, 2022
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Suven Pharmaceuticals acquires Casper Pharma for Rs 155 crore
By IPP Bureau - April 05, 2022
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
